Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02984839 · ClinicalTrials.gov registry record
Incidence of Residual Neuromuscular Blockade in Intra-abdominal Surgery: A Prospective, Observational Study
A clinical trial, sponsored by OhioHealth.
- Completed
- Registry status
- 120
- Enrollment target
NCT02984839: Completed study, sponsored by OhioHealth.
NCT02984839 is a clinical trial that has completed, run by OhioHealth. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02984839 has completed, sponsored by OhioHealth.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The aim of this prospective, observational study is to determine the incidence of post-operative residual neuromuscular blockade (PRNB) in patients undergoing intra-abdominal procedures compared to patients undergoing other noncardiac/non intra-thoracic procedures that also require non-depolarizing neuromuscular blocking agents (NMBA) administration. As intra-abdominal surgeries are independently associated with post-operative pulmonary complications (PPCs), it is important to highlight other factors, such as PRNB, that could contribute to these complications.Although it has been shown that the risk of adverse respiratory events can be reduced by intra-operative quantitative neuromuscular monitoring, such monitoring is not in widespread use.This study will incorporate quantitative monitoring in the post-anesthesia care unit (PACU) setting by using the Stimpod NMS450® in an effort to show a disparity in the incidence of residual paralysis between these two patient populations and to emphasize the need to implement more accurate neuromuscular monitoring, especially for those that are already at increased risk for respiratory complications.
Primary Outcome
Average TOF ratio will be calculated from two consecutive readings using the Stimpod NMS450 within 15 minutes of arrival in the PACU
Interventions
- DEVICE Stimpod NMS450® Nerve Stimulator, by Xavant™ Technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-05-16 |
What the finished NCT02984839 record still lists
NCT02984839 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Stimpod NMS450® Nerve Stimulator, by Xavant™ Technology is the first listed.
NCT02984839 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02984839 about?
NCT02984839 is a clinical study titled "Incidence of Residual Neuromuscular Blockade in Intra-abdominal Surgery: A Prospective, Observational Study". The aim of this prospective, observational study is to determine the incidence of post-operative residual neuromuscular blockade (PRNB) in patients undergoing intra-abdominal procedures compared to patients undergoing other noncardiac/non intra-thoracic procedures that also require non-depolarizing ...
What is the current status of trial NCT02984839?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2016-11. Estimated completion is 2017-05-16.
What interventions are being tested in trial NCT02984839?
The interventions under investigation include: Stimpod NMS450® Nerve Stimulator, by Xavant™ Technology (DEVICE).
Who is sponsoring clinical trial NCT02984839?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia